Exhibit 23.1

 

LOGO

  

LOGO

Independent Registered Public Accounting Firm’s Consent

We consent to the use in this Post-Effective Amendment No. 1 to the Registration Statement on Form S-1 of our report dated February 27, 2026 relating to the financial statements for the year ended December 31, 2025 and related notes of Semnur Pharmaceuticals, Inc. (formerly known as Denali Capital Acquisition Corp.) appearing in this Post-Effective Amendment No. 1 to the Registration Statement on Form S-1.

 

/s/ Pipara & Co LLP
New Delhi, India
May 12, 2026

 

 

 

 

 

New York Office:

1270, Ave of Americas,

Rockefeller Center, FL7,

New York – 10020,

USA

+1 (646) 387 - 2034

   

Corporate Office:

“Pipara Corporate House”

Near Bandhan Bank Ltd.,

Netaji Marg, Law Garden, Ahmedabad - 380006

   

Dubai Office:

1011, B-Block,

Mazaya Centre,

Sheikh Zayed Rd -

Al Wasl -Dubai -

UAE

   

Mumbai Office:

#3, 13th floor, Tradelink,

‘E’ Wing, A -Block, Kamala

Mills, Senapati Bapat

Marg, Lower Parel,

Mumbai - 400013

   

Delhi Office:

Green Park Desq Work,

Gate No. 1, 49/1 Yusuf Sarai, Nr. Green Park Metro Station, Delhi - 110016

   

Hyderabad Office:

509, Sandhya Techno -1, Opp. KIMS Hospital, Raidurgam, Hyderabad Telangana, India, 500036

           
naman@pipara.com    T: + 91 79 40 370370    info@pipara.com    E: pipara@pipara.com    chintan.jain@pipara.com    sharyansh.ranka@pipara.com